nalidixic acid has been researched along with isoniazid in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Dobson, RA; Johnson, RE; O'Connor, JR; Soria, AE | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
| Peraman, R; Reddy, YP; Varma, RV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Garcia, FS; Reinlein, JM | 1 |
| Atkinson, B; Lorian, V | 1 |
| Kimbel, KH | 1 |
| Plempel, M | 1 |
| Jackson, EA; McLeod, DC | 1 |
| Cuulston, F; Serrone, DM | 1 |
| Adhikary, A; Biswal, S; Chatterjee, D; Ghosh, AS | 1 |
3 review(s) available for nalidixic acid and isoniazid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Antimicrobial therapy in pregnancy (author's transl)].
Topics: Abortion, Spontaneous; Antimalarials; Antiviral Agents; Central Nervous System; Cephalosporins; DNA Replication; Female; Humans; Isoniazid; Maternal-Fetal Exchange; Methemoglobinemia; Molecular Weight; Nalidixic Acid; Pregnancy; Pregnancy Complications, Infectious; Protein Binding; Rifampin; Sulfonamides; Teratogens; Urinary Tract Infections | 1979 |
The comparative approach to the role of nonhuman primates in evaluation of drug toxicity in man: a review.
Topics: Animals; Birds; Cholinesterase Inhibitors; Detergents; Dimethyl Sulfoxide; Haplorhini; Hominidae; Intestine, Small; Isoniazid; Liver; Mammals; Microscopy, Electron; Models, Biological; Nalidixic Acid; Pesticides; Species Specificity; Toxicology | 1969 |
15 other study(ies) available for nalidixic acid and isoniazid
| Article | Year |
|---|---|
Synthesis and antibacterial activity of 1-(arylamino)-1H-pyrroles and 4-(1H-pyrrol-1-ylimino)-2,5-cyclohexadienes.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Biotransformation; Chemical Phenomena; Chemistry; Cyclohexanes; Female; Mice; Pyrroles; Rats; Rats, Inbred Strains | 1981 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nalidixic Acid; Proteus vulgaris; Structure-Activity Relationship | 2015 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Abnormal forms of bacteria produced by antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cephalothin; Chloramphenicol; Escherichia coli; Gentamicins; Isoniazid; Klebsiella pneumoniae; Mycobacterium tuberculosis; Nalidixic Acid; Neisseria gonorrhoeae; Nitrofurantoin; Penicillins; Proteus mirabilis; Salmonella typhimurium; Staphylococcus aureus; Streptococcus pneumoniae; Tetracycline | 1975 |
[Toxicological evaluation criteria (secondary action aspects)].
Topics: Anti-Infective Agents; Cephalosporins; Chloramphenicol; Erythromycin; Ethambutol; Gentamicins; Humans; Isoniazid; Lincomycin; Nalidixic Acid; Neomycin; Nitrofurantoin; Penicillins; Rifampin; Streptomycin; Sulfonamides; Tetracyclines | 1977 |
[Action mechanism of antibacterial and antifungal drugs].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacitracin; Bacteria; Cephalosporins; Chloramphenicol; Cycloserine; Daunorubicin; Fungi; Isoniazid; Mitomycins; Nalidixic Acid; Nystatin; Penicillins; Polymyxins; Puromycin; Sulfonamides | 1967 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin | 1974 |
A NiCoT family metal transporter of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cobalt; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Ethambutol; Gentamicins; Isoleucine; Isoniazid; Kanamycin; Leucine; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Neomycin; Nickel; Norfloxacin; Ofloxacin | 2022 |